Our Pricing

Mounjaro Northern Ireland Discount Code - £20 off first order using code WEIGHTLOSSNEW

Published on: June 03, 2026

Searching for a mounjaro northern ireland discount code? Cured Pharmacy offers Northern Ireland residents access to genuine UK-licensed Mounjaro (tirzepatide) injections from £124.99, with free clinical consultation from UK prescribers and discreet home delivery. Our transparent pricing means you know the exact cost before completing your online assessment, with no hidden fees or subscription charges.

How to Claim Your Mounjaro Northern Ireland Discount

Claiming your discount is straightforward at Cured Pharmacy. Northern Ireland patients simply complete the free online consultation, which takes under three minutes and is reviewed by our UK-registered clinical team. If Mounjaro is deemed clinically appropriate by your prescriber, you'll receive your prescription and your order will be dispensed from our GPhC-registered pharmacy (registration number 9012511) with the discount automatically applied at checkout.

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees every prescription to ensure compliance with MHRA guidelines and patient safety standards. All Mounjaro pens are genuine UK-licensed medications sourced directly from licensed wholesalers, never grey-market imports. Your medication arrives in 100% discreet packaging with tracked delivery across Northern Ireland, typically within 2-3 working days of prescriber approval.

What Is Mounjaro and How Does It Work for Weight Loss?

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in the UK [1]. Unlike single-pathway treatments such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, producing enhanced metabolic effects that support greater weight reduction.

In the landmark SURMOUNT-1 trial, participants receiving the 15mg maintenance dose of tirzepatide achieved an average body weight reduction of 20.9% over 72 weeks, compared to 3.1% in the placebo group [1]. The dual-agonist mechanism works by slowing gastric emptying, reducing appetite, improving insulin sensitivity, and increasing energy expenditure — all factors that contribute to sustained weight loss when combined with lifestyle modifications [2].

Who Can Use Mounjaro in Northern Ireland?

Mounjaro is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea [3]. Northern Ireland residents must undergo clinical assessment by a UK prescriber to confirm eligibility, as Mounjaro is a prescription-only medication that cannot be supplied without prescriber approval. Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and pregnancy or breastfeeding.

Mounjaro Dosing Schedule and What to Expect

Mounjaro follows a structured dose-escalation protocol designed to minimise gastrointestinal side effects whilst optimising weight loss outcomes. Treatment begins with a 2.5mg subcutaneous injection once weekly for four weeks, then increases to 5mg weekly for the next four weeks [3]. Your prescriber may continue escalating the dose every four weeks through 7.5mg, 10mg, 12.5mg, and up to the maximum maintenance dose of 15mg weekly, depending on your tolerance and clinical response.

Most patients begin noticing appetite reduction within the first week of treatment, with measurable weight loss typically evident by weeks 4-8. In clinical trials, the median time to achieve 5% body weight reduction was approximately 12 weeks on the 15mg dose [1]. It's essential to continue the prescribed dose schedule even if initial weight loss seems modest, as the full therapeutic effect develops over several months of consistent use alongside dietary modifications and increased physical activity.

Managing Common Side Effects

The most frequently reported side effects in clinical trials were gastrointestinal: nausea (affecting up to 30% of participants), diarrhoea, vomiting, constipation, and abdominal discomfort [1][3]. These effects are typically mild to moderate, occur most commonly during dose escalation, and diminish over time as your body adjusts. Eating smaller, more frequent meals, avoiding high-fat foods, and staying well-hydrated can help manage these symptoms. If side effects become severe or persistent, contact your prescriber to discuss dose adjustment or alternative treatment options.

Comparing Mounjaro Pricing Across Northern Ireland Pharmacies

Pricing transparency remains a significant challenge when comparing weight loss treatments across UK pharmacies. Many providers require patients to complete lengthy consultations before revealing the actual cost, whilst others embed pricing within subscription models that obscure the true monthly expense. At Cured Pharmacy, we display exact pricing upfront, with no hidden consultation fees, subscription lock-ins, or mandatory follow-up charges.

Our pricing structure reflects the genuine cost of UK-licensed medication, prescriber review, and pharmacy dispensing services. Northern Ireland patients benefit from the same competitive rates as customers across the UK, with the discount applied automatically to first orders. We guarantee the lowest prices on genuine UK-licensed Mounjaro in the UK market, and if you find a lower price from another GPhC-registered pharmacy for the same product, we'll match it.

Alternative Weight Loss Treatments Available in Northern Ireland

Whilst Mounjaro demonstrates superior efficacy in head-to-head trials, several other prescription weight loss medications are licensed and available through Cured Pharmacy for Northern Ireland residents. Wegovy (semaglutide) is a once-weekly GLP-1 receptor agonist that achieved an average 14.9% body weight reduction over 68 weeks in the STEP-1 trial [4]. Saxenda (liraglutide) requires daily injection and produced an average 8.0% weight loss over 56 weeks in the SCALE trial [5].

For patients who prefer oral medications or have needle aversion, Orlistat (available as branded Xenical or generic formulations) works by blocking approximately 30% of dietary fat absorption. Orlistat is most effective for patients who can adhere to a reduced-calorie, lower-fat diet, with clinical trials demonstrating an average additional 2.9 kg weight loss compared to diet alone over 12 months [6]. Your UK prescriber will recommend the most appropriate treatment based on your medical history, weight loss goals, lifestyle factors, and budget considerations.

Combination Approaches and Lifestyle Support

No weight loss medication works effectively in isolation. NICE guidelines emphasise that pharmacological interventions should be prescribed alongside a comprehensive programme of dietary modification, increased physical activity, and behavioural support [7]. At Cured Pharmacy, our clinical team provides guidance on evidence-based lifestyle strategies that complement your medication, including practical advice on portion control, meal timing, protein intake optimisation, and sustainable exercise routines that fit your current fitness level and daily schedule.

How Cured Pharmacy's Northern Ireland Service Works

Our streamlined process ensures Northern Ireland residents can access prescription weight loss treatments quickly and discreetly. Start by completing the free online consultation, which asks about your medical history, current medications, weight loss goals, and any contraindications. Your responses are reviewed within hours by a UK-registered prescriber who will assess clinical appropriateness and issue a prescription if suitable. Once approved, your medication is dispensed from our GPhC-registered pharmacy and dispatched via tracked courier in unmarked packaging.

We accept all major payment methods and never store card details beyond the secure payment gateway. Your personal health information is handled in strict accordance with UK GDPR and NHS data protection standards. If you have questions before, during, or after your treatment, our pharmacy team is available by phone on (+44) 116 4646009 during business hours. Follow-up consultations for dose adjustments or side effect management are provided at no additional charge, ensuring continuous clinical support throughout your weight loss journey.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen – Summary of Product Characteristics. Medicines.org.uk. https://www.medicines.org.uk/emc/product/14298 [accessed 13 August 2026]
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
5. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
6. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
7. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
8. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
9. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
10. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to lifestyle modifications.